DGCR8 and acute myeloid leukemia: While DGCR8 and DICER1 emerged as promising diagnostic indicators, particularly in AML, the observed variability in gene-specific sensitivity and specificity, together with the limited size of the control cohort, indicates that these results should be interpreted with caution.